These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 5071762)

  • 21. [Biochemical principles of the development of new cardiac drugs of the digitalis type].
    Repke KR
    Pharmazie; 1972 Nov; 27(11):693-701. PubMed ID: 4265944
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: On the kinetics of tritiated digoxigenin-monodigitoxoside in the guinea-pig.
    Proppe D
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R77. PubMed ID: 4276631
    [No Abstract]   [Full Text] [Related]  

  • 23. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].
    Erdmann E
    Arzneimittelforschung; 1978; 28(3a):531-5. PubMed ID: 148278
    [No Abstract]   [Full Text] [Related]  

  • 26. [Correction of the incorrectly measured Hatcher-Brody optimal titer of cardiotonic steroids. Determination of the molar optimal titer at long survival time].
    Vogel G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):320. PubMed ID: 4242454
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metabolic degradation of 3H-labelled cardiac glycosides by the isolated perfused guinea pig liver].
    Kolenda KD; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):374-5. PubMed ID: 4253809
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of the plasma protein binding of cardiac glycosides by measuring the Na plus-K+ transport in erythrocytes].
    Kobinger W; Wenzel B
    Wien Klin Wochenschr; 1970 Mar; 82(11):195-9. PubMed ID: 5535107
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042
    [No Abstract]   [Full Text] [Related]  

  • 30. Elimination of cardiac glycosides through hemofiltration.
    Kramer P; Matthias C; Matthaei D; Scheler F
    J Dial; 1977; 1(7):689-95. PubMed ID: 608877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
    Rietbrock N
    Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple approach to follow the metabolic degradation of cardiac glycosides in vivo.
    Glover A; Kokenge F; Lüllmann H; Peters T; Seiler KU; van Zweiten PA
    Klin Wochenschr; 1971 Oct; 49(19):1062-5. PubMed ID: 5115325
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 34. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 35. Species difference in duration of action of cardiac glycosides.
    Okita GT
    Fed Proc; 1967; 26(4):1125-30. PubMed ID: 6028775
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma elimination, hepatic uptake and biliary excretion of tritiated cardiac glycosides by the isolated perfused liver].
    Kolenda KD; Peters T; Seiler KU
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):375-6. PubMed ID: 4253810
    [No Abstract]   [Full Text] [Related]  

  • 37. Digitalis glycosides. Pharmacokinetics and their clinical implications.
    Doherty JE
    Ann Intern Med; 1973 Aug; 79(2):229-38. PubMed ID: 4580113
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man].
    Dengler HJ; Bodem G; Wirth K
    Arzneimittelforschung; 1973 Jan; 23(1):64-74. PubMed ID: 4740698
    [No Abstract]   [Full Text] [Related]  

  • 39. [Behavior of digoxin, digitoxin and digitoxigenin in isolated heart muscle and in plasma of reserpinized guinea pigs].
    Kuschinsky K; van Zwieten PA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(4):463-73. PubMed ID: 4180717
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of digoxin in relation to therapy in the elderly.
    Caird FI
    Gerontol Clin (Basel); 1974; 16(1):68-74. PubMed ID: 4604761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.